Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
T-cell therapy
Fierce Pharma
FDA to reconsider rejected cell therapy. Could uniQure be next?
As the FDA walks back its previous criticism of Ebvallo's single-arm trial, there's hope for a reversal for uniQure's gene therapy, too.
Angus Liu
May 7, 2026 10:40am
Pfizer, Sanofi round out '25 with separate autoimmune deals
Dec 15, 2025 11:06am
Fierce Pharma
J&J, Legend pull ASH paper comparing Carvykti to rival CAR-T
Nov 12, 2025 11:36am
Wugen woos VCs, landing $115M to bring CAR-T therapy to market
Aug 27, 2025 8:10am
Allogene lays off 28% of staff to save cash amid program delays
May 14, 2025 8:00am
Kiromic furloughs 'substantially all' workers amid cash crunch
Mar 18, 2025 5:42am
